GlassScriptPhysician profile
Kamyar Assil
NPI 1750321568
$4,975.46
in general payments reported to CMS, 2019-2025
20 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $314 · 2021: $746 · 2022: $1,041 · 2023: $788 · 2024: $1,500 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,474.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,707.86 | 2019-2024 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $861.25 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $781.05 | 2022-2025 | Sprint Pns System |
| Medtronic, INC. | $672.19 | 2022-2025 | Accurian, Intellis Adaptivestim, Synchromedii |
| Vertiflex, INC. | $194.64 | 2019 | |
| Nevro Corp. | $178.01 | 2022 | |
| Medtronic USA, INC. | $87.93 | 2019-2020 | |
| Nalu Medical, INC. | $87.79 | 2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $65.15 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $57.15 | 2022 | |
| Stryker Corporation | $55.83 | 2024 | Mild Device Kit |
| Pacira Pharmaceuticals Incorporated | $51.64 | 2024-2025 | Exparel, Zilretta |
| Pfizer INC. | $48.32 | 2021 | |
| Bioventus LLC | $21.54 | 2025 | Xcell |
| Scilex Pharmaceuticals INC. | $20.67 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $20.39 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $19.93 | 2021 | |
| Relievant Medsystems, INC. | $17.39 | 2021 | |
| Biodelivery Sciences International, INC. | $14.74 | 2021 | |
| Horizon Therapeutics Plc | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamyar Assil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.